In November, South Africa and India teamed up to take a bold stance at the World Trade Organisation. African countries continue to be the most vulnerable, given the burden of underlying medical conditions and under-resourced health systems. The South African government has been exemplary in standing up for public health and many African leaders have consequently recognised the negative impact of IP on access to Covid-19 medical tools. The Africa CDC Consortium for Covid-19 Vaccine Clinical Trials (CONCVACT) and the Covid-19 Vaccine Development strategy both highlight the need for vaccine manufacturing scale-up to meet global demand for Covid-19 medical products. - Candice Sehoma is the Access Campaign Advocacy Officer for Doctors Without Borders (MSF) in South Africa.

Source: News 24 December 07, 2020 03:22 UTC